Park, Hyo Jung
Lee, Tae Young
Kim, So Yeon
Kim, Min-Ju
Singal, Amit G.
Lee, So Jung
Won, Hyung Jin
Byun, Jae Ho
Lim, Young-Suk
Funding for this research was provided by:
National Institutes of Health (U01 CA230694)
Article History
Received: 3 September 2021
Revised: 25 January 2022
Accepted: 31 January 2022
First Online: 28 February 2022
Declarations
:
: The scientific guarantor of this publication is So Yeon Kim.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors (Minju Kim) has significant statistical expertise.
: Written informed consent was waived by the institutional review board.
: Institutional review board approval was obtained.
: Study subjects or cohorts have been previously reported in the articles below.1. Kim SY, An J, Lim YS et al (2017) MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma. <i>JAMA Oncol</i> 3:456-4632. Park HJ, Jang HY, Kim SY et al (2020) Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: comparison with ultrasound. <i>J Hepatol</i> 72:718-724
: • retrospective• observational study• performed at one institution